Stanford Dermatology Clinics
Stanford Medicine Outpatient Center
450 Broadway Street
Pavilion B, 4th Floor
Redwood City, CA 94063
Directions >>

Welcome to the Department of Dermatology at Stanford University. Our mission is to provide sustained leadership in scientific investigation, patient care, and in training leaders of our specialty in an environment that fosters creativity and synergy.

Our faculty is committed to the highest level of basic and clinical research in dermatologic science. In particular, we are focused on translational medicine; bringing scientific results from the bench to the bedside.

Our faculty practices medicine at a world-class hospital; and are internationally recognized for the medical and surgical dermatologic care they provide to their patients.

Our vision is to train future leaders in dermatology, whether in scientific investigation or patient care. The competitiveness of our residency program speaks to the commitment our faculty has to our residents and medical students..

---

New Stanford Dermatology Clinic Opens
for Cancer Patients with Skin Problems

Jean Tang, MD, PhD,
with 101-year-old Winnie Bazurto

Three years ago, 101-year-old winnie Bazurto noticed a strange growth on her lower eyelid. She didn't worry about it initially, but in 2012 it started getting bigger, fast -- doubling in size every two weeks and growing into the orbit of her right eye, restricting her vision.

Diagnosed as basal cell carcinoma, the most common skin cancer, her main concern was that the painful growth would infiltrate the eyeball, possibly causing blindness. Bazurto's options for treatment didn't look good, until the option of a new drug approved by the U.S. Food and Drug Administration emerged.

Read the full Inside Stanford Medicine article>>

Anne Chang, MD, Anthony Oro, MD, PhD,
and Jean Tang, MD, PhD

Sixteen years ago, Dr. Anthony Oro was part of the team that discovered the connection between the hedgehog pathway and human cancer. In February 2012, the first hedgehog pathway inhibitor was approved by the FDA. This new drug has been shown to be effective in treating and preventing the most common cancer in the United States, basal cell carcinoma (BCC) of the skin in three independent studies published in the New England Journal of Medicine (NEJM) on June 7, 2012.

More on hedgehog pathway research>>